Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
"I couldn't carry on taking a drug like that": A qualitative study of patient perspectives on side effects from rheumatology drugs.
Berthelsen DB, Nielsen SM, Rasmussen MU, Voshaar M, Richards P, Bartlett SJ, Hazlewood GS, Shea BJ, Tugwell P, Ellingsen T, Jørgensen TS, Kristensen S, Simon LS, Christensen R, Flurey CA; OMERACT Safety Working Group. Berthelsen DB, et al. Among authors: shea bj. Rheumatology (Oxford). 2024 Apr 13:keae223. doi: 10.1093/rheumatology/keae223. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38613847
Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials.
Andersen KM, Cheah JTL, March L, Bartlett SJ, Beaton D, Bingham CO 3rd, Brooks PM, Christensen R, Conaghan PG, D'Agostino MA, de Wit M, Dueck AC, Goodman SM, Grosskleg S, Hill CL, Howell M, Mackie SL, Richards B, Shea B, Singh JA, Strand V, Tugwell P, Wells GA, Simon LS. Andersen KM, et al. J Rheumatol. 2019 Aug;46(8):1053-1058. doi: 10.3899/jrheum.181123. Epub 2019 Jan 15. J Rheumatol. 2019. PMID: 30647191 Free article.
OMERACT consensus-based operational definition of contextual factors in rheumatology clinical trials: A mixed methods study.
Nielsen SM, Boers M, de Wit M, Shea B, van der Windt DA, Reeves BC, Beaton D, Alten R, Toupin April K, Boonen A, Escorpizo R, Flurey C, Furst DE, Guillemin F, Leong A, Pohl C, Rasmussen MU, Singh JA, Smolen JS, Strand V, Verstappen SMM, Voshaar M, Woodworth TG, Ellingsen T, March L, Wells GA, Tugwell P, Christensen R. Nielsen SM, et al. Semin Arthritis Rheum. 2021 Jun;51(3):601-606. doi: 10.1016/j.semarthrit.2021.03.013. Epub 2021 Apr 2. Semin Arthritis Rheum. 2021. PMID: 33875246 Free article.
Stakeholder endorsement advancing the implementation of a patient-reported domain for harms in rheumatology clinical trials: Outcome of the OMERACT Safety Working Group.
Berthelsen DB, Simon LS, Ioannidis JPA, Voshaar M, Richards P, Goel N, Strand V, Nielsen SM, Shea BJ, Tugwell P, Bartlett SJ, Hazlewood GS, March L, Singh JA, Suarez-Almazor ME, Boers M, Stevens RM, Furst DE, Woodworth T, Leong A, Brooks PM, Flurey C, Christensen R; OMERACT Safety Working Group. Berthelsen DB, et al. Among authors: shea bj. Semin Arthritis Rheum. 2023 Dec;63:152288. doi: 10.1016/j.semarthrit.2023.152288. Epub 2023 Oct 26. Semin Arthritis Rheum. 2023. PMID: 37918049
Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials.
Décary S, de Wit M, Naye F, Barton JL, Fraenkel L, Li LC, Brooks P, Stacey D, Maxwell LJ, Campbell W, Hofstetter C, Voshaar M, Meara A, Christensen R, Boonen A, Suarez-Almazor ME, Meade T, March L, Jull JE, Alten R, Morgan EM, Stewart Hazlewood G, Barber CEH, Guillemin F, El-Miedany Y, Mittoo S, Robertson TW, Bartlett SJ, Singh JA, Mannion M, Nasef SI, Boel A, Adebajo A, Arnaud L, Gill TK, Moholt E, Burt J, Jayatilleke A, Hmamouchi I, Berthelsen DB, Blanco FJ, Mather K, Maharaj A, Sharma S, Caso F, Beaton D, Shea B, Fong C, Fernandez AP, Mackie S, Nikiphorou E, Jones A, Greer-Smith R, Sloan VS, Akpabio A, Strand V, Lee RR, Umaefulam V, Monti S, Abaza N, Schultz G, Stones S, Gossec L, Nielsen SM, Cavallo S, Srinivasalu H, Constien D, Evans V, Tugwell P, Toupin-April K. Décary S, et al. Semin Arthritis Rheum. 2024 Apr;65:152381. doi: 10.1016/j.semarthrit.2024.152381. Epub 2024 Jan 15. Semin Arthritis Rheum. 2024. PMID: 38306813
Patient preferences to value health outcomes in rheumatology clinical trials: Report from the OMERACT special interest group✰.
Thomas M, Fraenkel L, Boonen A, Bansback N, Buchbinder R, Marshall D, Proulx L, Voshaar M, Richards P, Richards DP, Hiligsmann M, Guillemin F, Shea B, Tugwell P, Hazlewood G. Thomas M, et al. Semin Arthritis Rheum. 2021 Aug;51(4):919-924. doi: 10.1016/j.semarthrit.2021.05.008. Epub 2021 May 24. Semin Arthritis Rheum. 2021. PMID: 34134892
PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials.
Orbai AM, Holland R, Leung YY, Tillett W, Goel N, Christensen R, McHugh N, Gossec L, de Wit M, Højgaard P, Coates LC, Mease PJ, Birt J, Fallon L, FitzGerald O, Ogdie A, Shea B, Strand V, Duffin KC, Tugwell P, Beaton D, Gladman DD. Orbai AM, et al. J Rheumatol. 2019 Aug;46(8):990-995. doi: 10.3899/jrheum.181077. Epub 2018 Dec 15. J Rheumatol. 2019. PMID: 30554154 Free PMC article. Review.
133 results